Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 11Gastrointestinal 2Breast 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Subclinical Breast Cancer Lesion 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Gadolinium × Breast × Clear all
NCT06512558 2025-12-31

AR-GBS

Centre Jean Perrin

Phase NA Recruiting
20 enrolled
Breast

Subclinical Breast Cancer Lesion

NCT02587663 2019-05-16

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

University of Southern California

Phase NA Completed
300 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡